Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
riccardo.lombardo@uniroma1.it
Riccardo Lombardo
Dottorando
Struttura:
DIPARTIMENTO DI SCIENZE CHIRURGICHE
E-mail:
riccardo.lombardo@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
A systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancer
PROSTATE CANCER AND PROSTATIC DISEASES
2024
Quality of information and appropriateness of ChatGPT outputs for neuro-urology
MINERVA UROLOGY AND NEPHROLOGY
2024
Post-Voided Residual Ratio Does Not Predict Trifecta Outcome after Transurethral Resection of Prostate
LIFE
2024
Letter to the Editor on "Predictors of Early Continence after Single-Port Transvesical Robot-Assisted Radical Prostatectomy"
UROLOGY
2024
Prostatectomy in oligometastatic prostate cancer: a call for high-quality evidence
PROSTATE CANCER AND PROSTATIC DISEASES
2024
Ejaculation sparing of classic and minimally invasive surgical treatments of LUTS/BPH
PROSTATE CANCER AND PROSTATIC DISEASES
2024
Re: James P. Buteau, Daniel Moon, Michael T. Fahey, et al. Clinical Trial Protocol for PRIMARY2: A Multicentre, Phase 3, Randomised Controlled Trial Investigating the Additive Diagnostic Value of [68Ga]Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Negative or Equivocal Multiparametric Magnetic Resonance Imaging for the Diagnosis of Clinically Significant Prostate Cancer. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.11.008
EUROPEAN UROLOGY ONCOLOGY
2024
Treatment preferences of patients with erectile dysfunction: a systematic review of randomized controlled trials
MINERVA UROLOGY AND NEPHROLOGY
2024
Major adverse cardiovascular events related to phosphodiesterase 5 inhibitors: analysis of real-life data from Eudra-Vigilance database
MINERVA UROLOGY AND NEPHROLOGY
2024
Letter: Cardiovascular Risk in Prostate Cancer Patients Using Luteinizing Hormone‒Releasing Hormone Agonists or a Gonadotropin-Releasing Hormone Antagonist
THE JOURNAL OF UROLOGY
2024
Evaluation of peri-operative outcomes after prostatic urethral lift with emphasis on urodynamic changes, symptom improvement and sexual function
DIAGNOSTICS
2024
Impact of diabetes mellitus on oncologic outcomes in patients receiving robot-assisted radical cystectomy for bladder cancer
WORLD JOURNAL OF UROLOGY
2024
No clinical benefit from sequential combination of mitomycin C plus bacillus Calmette-Guérin (BCG) than BCG alone in the adjuvant treatment of high risk non muscle invasive bladder cancer: result of a planned interim analysis of a prospective randomized trial
MINERVA UROLOGY AND NEPHROLOGY
2024
Transvaginal natural orifice transluminal endoscopic surgery (vNOTES) in urogynecological surgery: a systematic review
JOURNAL OF CLINICAL MEDICINE
2024
Complication rate across the minimally invasive surgical treatments (MISTs): where do we stand? A systematic review of the literature
PROSTATE CANCER AND PROSTATIC DISEASES
2024
Patients’ Preferences and Expectations in Overactive Bladder: A Systematic Review
JOURNAL OF CLINICAL MEDICINE
2023
Is There a Role of Warburg Effect in Prostate Cancer Aggressiveness? Analysis of Expression of Enzymes of Lipidic Metabolism by Immunohistochemistry in Prostate Cancer Patients (DIAMOND Study)
CANCERS
2023
Best of 2022 in prostate cancer and prostatic diseases
PROSTATE CANCER AND PROSTATIC DISEASES
2023
Physical Inactivity, Metabolic Syndrome and Prostate Cancer Diagnosis: Development of a Predicting Nomogram
METABOLITES
2023
Cardiovascular adverse events-related to GnRH agonists and GnRH antagonists: analysis of real-life data from Eudra-Vigilance and Food and Drug Administration databases entries
PROSTATE CANCER AND PROSTATIC DISEASES
2023
« prima
< precedente
1
2
3
4
5
6
7
8
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma